Literature DB >> 6790572

Neisseria gonorrhoeae strains inhibited by vancomycin in selective media and correlation with auxotype.

S Mirrett, L B Reller, J S Knapp.   

Abstract

Strains of Neisseria gonorrhoeae that failed to grow on Thayer-Martin (T-M) and Martin-Lewis (M-L) media accounted for 2.0% of isolates at the University of Colorado Hospital and its Venereal Disease Clinic. A total of 31 inhibited and 31 control strains were compared by agar dilution testing for their susceptibilities to 13 antimicrobial agents used for treatment or in selective media. All 62 isolates were resistant to lincomycin, colistin, nystatin, amphotericin B, trimethoprim lactate, polymyxin B, and anisomycin. Vancomycin was the inhibitory antibiotic for N. gonorrhoeae in both T-M and M-L media. The vancomycin-inhibited strains were also significantly more sensitive to penicillin and ampicillin than were the control strains (P less than 0.001). The presence of the other antibiotics in selective media did not affect the minimum inhibitory concentrations of vancomycin for gonococci. All 31 inhibited strains were sensitive to 8.0 micrograms of vancomycin per ml, and 26 of these were sensitive to 2.0 microgram/ml. Decreasing the size of inoculum of gonococci results in greater inhibition by any given concentration of vancomycin. The vancomycin-sensitive strains contained significantly more arginine- hypoxanthine-, and uracil-requiring auxotypes (28 out of 31) than did the control strains (9 out of 31). As with T-M medium, some strains of gonococci will be missed when M-L medium with 4.0 micrograms of vancomycin per ml is the only medium used for the diagnosis of gonorrhea. This may be of particular importance in the confirmation of disseminated infection with Arg- Hyx- Ura- auxotypes of N. gonorrhoeae when cultures of blood, joint fluid, or skin lesions are negative.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6790572      PMCID: PMC271907          DOI: 10.1128/jcm.14.1.94-99.1981

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  23 in total

1.  Comparison of a selective and a non-selective medium in the diagnosis of gonorrhoea to ascertain the sensitivity of Neisseria gonorrhoeae to vancomycin.

Authors:  A Reyn; M W Bentzon
Journal:  Br J Vener Dis       Date:  1972-10

2.  Vancomycin-sensitive strains of Neisseria gonorrhoeae. A problem for the diagnostic laboratory.

Authors:  J E Brorson; I Holmberg; B Nygren; S Seeberg
Journal:  Br J Vener Dis       Date:  1973-10

3.  Gonogrow, an improved, selective medium for the isolation of Neisseria gonorrhoeae.

Authors:  N C Chen; S S Hipp; W D Lawton; H A Gaafar
Journal:  Health Lab Sci       Date:  1974-07

4.  Trimethoprim for the prevention of overgrowth by swarming Proteus in the cultivation of gonococci.

Authors:  K Odegaard
Journal:  Acta Pathol Microbiol Scand B Microbiol Immunol       Date:  1971

5.  VCN--inhibited strains of Neisseria gonorrhoeae.

Authors:  R C Cross; M B Hoger; R Neibaur; B Pasternack; F J Brady
Journal:  HSMHA Health Rep       Date:  1971-11

6.  Gonococcal arthritis. A survey of 54 cases.

Authors:  C L Cooke; D S Owen; R Irby; E Toone
Journal:  JAMA       Date:  1971-07-12       Impact factor: 56.272

7.  Use of trimethoprim to prevent overgrowth by Proteus in the cultivation of N. gonorrhoeae.

Authors:  A Seth
Journal:  Br J Vener Dis       Date:  1970-06

8.  Disseminated gonococcal infections caused by Neisseria gonorrhoeae with unique nutritional requirements.

Authors:  J S Knapp; K K Holmes
Journal:  J Infect Dis       Date:  1975-08       Impact factor: 5.226

9.  Superiority of amphotericin over nystatin in Thayer-Martin medium.

Authors:  E Whitbeck; N Shemonsky; M E Levison
Journal:  Antimicrob Agents Chemother       Date:  1975-05       Impact factor: 5.191

10.  Trimethoprim as an additional selective agent in media for the isolation of N. gonorrhoeae.

Authors:  R H Riddell; A C Buck
Journal:  J Clin Pathol       Date:  1970-09       Impact factor: 3.411

View more
  14 in total

1.  Effect of holding temperature on isolation of Neisseria gonorrhoeae.

Authors:  K D Evans; E M Peterson; J I Curry; J R Greenwood; L M de la Maza
Journal:  J Clin Microbiol       Date:  1986-12       Impact factor: 5.948

Review 2.  Molecular epidemiology of gonorrhea.

Authors:  S K Sarafian; J S Knapp
Journal:  Clin Microbiol Rev       Date:  1989-04       Impact factor: 26.132

3.  Vancomycin hypersusceptibility in Neisseria gonorrhoeae isolated from patients involves diverse mutations.

Authors:  J A Koelbl; B W Catlin
Journal:  Antimicrob Agents Chemother       Date:  1986-04       Impact factor: 5.191

4.  Auxotypes and antibacterial resistance to gonococci with differing susceptibilities to vancomycin.

Authors:  A C Exner; E N Shinners; P J Pace; B W Catlin
Journal:  Br J Vener Dis       Date:  1982-06

5.  Comparison of GC-Lect and modified Thayer-Martin media for isolation of Neisseria gonorrhoeae.

Authors:  C A Reichart; L M Rupkey; W E Brady; E W Hook
Journal:  J Clin Microbiol       Date:  1989-05       Impact factor: 5.948

6.  New selective medium for the isolation of Neisseria gonorrhoeae.

Authors:  G L Evans; D L Kopyta; K Crouse
Journal:  J Clin Microbiol       Date:  1989-11       Impact factor: 5.948

Review 7.  Laboratory methods in genitourinary medicine. Methods of diagnosing gonorrhoea.

Authors:  C A Ison
Journal:  Genitourin Med       Date:  1990-12

8.  Isolation of Neisseria gonorrhoeae on selective and nonselective media in a sexually transmitted disease clinic.

Authors:  P Bonin; T T Tanino; H H Handsfield
Journal:  J Clin Microbiol       Date:  1984-02       Impact factor: 5.948

9.  Validity of an enzyme immunoassay for detection of Neisseria gonorrhoeae antigens.

Authors:  C J Papasian; W R Bartholomew; D Amsterdam
Journal:  J Clin Microbiol       Date:  1984-03       Impact factor: 5.948

10.  Evaluation of novel vancomycin-containing medium for primary isolation of Kingella kingae from upper respiratory tract specimens.

Authors:  P Yagupsky; M Merires; J Bahar; R Dagan
Journal:  J Clin Microbiol       Date:  1995-05       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.